Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 13, 2013
P63 - an important player in epidermal and tumour developmentP Orzol, M Nekulova, B Vojtesek, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|April 13, 2013
A combined immunoprecipitation and mass spectrometric approach to determine deltaNp63-interacting partnersL Hernychova, M Nekulova, D Potesil, et al.
Hepato-Gastroenterology|May 6, 1999
Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liverJ Zaloudik, L Lauerova, L Janakova, et al.
Oncology|January 1, 1987
Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) StudyS Kerpel-Fronius, F Gyergyay, I Hindy, et al.
Neoplasma|January 1, 1987
Comparative evaluation of two administration schedules of cis-dichlorodiammineplatinum (DDP) in ovarian and head and neck cancers: a CMEA chemotherapy group studyZ Mechl, S Kerpel-Fronius, A Decker, et al.
British Journal of Cancer|September 4, 2008
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panelK Oikonomopoulou, L Li, Y Zheng, et al.
Pageof 1